Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Breast Cancer Research
  • View item
  • Home
  • ICR Divisions
  • Breast Cancer Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment

Thumbnail
View/Open
Accepted version (2.296Mb)
Date
2021-07-19
ICR Author
Pasha, Nida
Turner, Nicholas
Author
Pasha, N
Turner, NC
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/4956
DOI
https://doi.org/10.1038/s43018-021-00229-1
https://doi.org/10.1038/s43018-021-00229-1
 
Collections
  • Breast Cancer Research
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
FIRST-LINE THERAPY
PHASE-III
TRASTUZUMAB EMTANSINE
POSTMENOPAUSAL WOMEN
CLONAL EVOLUTION
ESR1 MUTATIONS
DOUBLE-BLIND
INTRATUMOR HETEROGENEITY
ARTIFICIAL-INTELLIGENCE
MOLECULAR PORTRAITS
Research team
Molecular Oncology
Language
eng
Date accepted
2021-06-02
License start date
2021-07-19
Citation
NATURE CANCER, 2021, 2 (7), pp. 680 - 692 (13)
Publisher
NATURE PORTFOLIO

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.